Testing effectiveness (Phase 2)UnknownNCT06099925
What this trial is testing
The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies
Who this might be right for
Chemotherapy-induced Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 48